Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2011) 27 P84

BSPED2011 Poster Presentations (1) (84 abstracts)

Mevalonic aciduria in a pedigree with presumed GH-insensitivity

Evelien Gevers 1 , Daniel Kelberman 1 , Simon Aylwin 2 , Charles Buchanon 2 , Hans Waterham 3 & Mehul Dattani 1


1Institute of Child Health/Great Ormond Street Hospital, London, UK; 2King’s College Hospital NHS Trust, London, UK; 3Lab Genetic Metabolic Diseases, Academic Medical Center, Amsterdam, The Netherlands.


Mutations in GHR, STAT5B and IGF1 lead to GH-insensitivity but often the cause of reduced GH-sensitivity remains unknown. We describe the identification of a mutation in the MVK gene encoding mevalonate kinase (MK) in a pedigree investigated for STAT5B-deficiency.

A 15-year-old male born to consanguineous parents was referred for short stature (height 125.8 cm; −5.6 SDS) and arthritis. He presented, aged 2 years, with fever and poly-arthritis, and continued to have episodes of fever, hepatosplenomegaly and gastritis/duodenitis, and developed cataracts. A liver biopsy showed sclerosing cholangitis. He was on steroid treatment for presumed auto-immune disease. Pubertal development was delayed. The peak GH in response to provocation was 6 μg/l. Plasma IGF1-concentration was 27 μg/l (140–887) and IGFBP3 1.05 mg/l (3–8 mg/l). GH-treatment (6–10 mg/m2 per week) had little effect on growth and IGF1-concentration. One affected sister died of peritonitis. Two sisters had short stature, poly-arthritis and delayed puberty; one received GH-treatment with little effect. Six siblings were unaffected.

Microsatellite analysis and homozygosity screening of three affected and four unaffected family members pointed to a region on chromosome 12q24, not containing STAT5B. Candidate gene sequencing excluded SOCS2 mutations and detected a novel homozygous missense mutation (p.Val310Leu) in MVK in all three affected siblings, affecting a highly conserved valine; a previously described p.Val310Met mutation resulted in severe MK-deficiency. The mother and two unaffected siblings were heterozygous. The third unaffected sibling and 100 controls did not carry the mutation. MK is the enzyme following HMG-CoA in isoprenoid and cholesterol biosynthesis, important for several cellular processes. MK-deficiency leads to mevalonic aciduria, characterised by short stature, developmental delay, hepatosplenomegaly, arthritis, cataract and periodic inflammation, or the milder hyperimmunoglobulinaemia D. In conclusion, mevalonic aciduria was revealed in a pedigree with presumed GH-insensitivity. Growth failure is likely due to a combination of liver dysfunction, inflammation, steroid treatment and possibly MK-deficiency directly.

Volume 27

39th Meeting of the British Society for Paediatric Endocrinology and Diabetes

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts